Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Revive Meds

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Revive Meds head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 268 · Grade C

Revive Meds

Visit Revive Meds Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 65 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Revive Meds a bad call — it's best for readers interested in ordering without an advertised membership who can obtain a written prescription quote and cancellation agreement first. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
36
Supply Reliability
95
75
Transparency
90
48
Access Breadth
93
90
Clinical Oversight
92
80
Track Record
88
78
CoreAge RxBrief Score 94 · 65Revive Meds

Price, coverage & the tracker

CoreAge RxRevive Meds
Brief Score94/100 (A)65/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Confirm current medication quote

Compounded injection described; earlier $369/month listing is historical, not a current advertised total.

No membership or visit fee and free shipping advertised; confirm selected order supply and financial terms.

Full price details

Compounded semaglutide injection offered; current complete medication quote unknown; earlier listing from $369/month is historical and not confirmed by the current public program

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Confirm current medication quote

Compounded injection described; earlier $459/month listing is historical, not a current advertised total.

Nonapproval releases the stated card hold; thirty-day support language describes adjustment or credit, not guaranteed cash back.

Full price details

Compounded tirzepatide injection offered; current complete medication quote unknown; earlier listing from $459/month is historical and not confirmed by the current public program

CoverageUS only; restrictions by state, confirmed at intakeAdvertises care in all fifty states; specific services vary by provider licensing and state requirements
Brand-name accessNot confirmedReviewed named GLP-1 programs are compounded injections; current branded fulfillment was not established.
Oral / sublingualInjection onlyUnconfirmed
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Revive Meds: Current compounded injection programs described; full selected quotes unconfirmed. Earlier $369/$459 monthly observations are historical, not current advertised totals.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.